Crossbeam Venture Partners participated in Optain's $26M Series A round led by Insight Partners. Optain is a healthcare technology company.
Optain is a global medical device and software company specializing in AI-powered oculomics, providing a fast, non-invasive retinal screening platform to detect chronic diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration, and cardiovascular disease
Optain is a global medical device and software company specializing in AI-powered oculomics, providing a fast, non-invasive retinal screening platform to detect chronic diseases such as glaucoma, diabetic retinopathy, age-related macular degeneration, and cardiovascular disease.